UGCG and ovarian cancer: The role of P-gp in ceramide neutralization was further explored in work by Chapman et al. [164], who demonstrated that multidrug-resistant, P-gp-expressing ovarian cancer cells have an enhanced capacity for conversion of ceramide to GlcCer while the levels of GCS enzyme activity, measured in cell-free assays, were the same.